Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

EMERYVILLE, Calif., April 24, 2024 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the U.S….

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks